Amphastar P
Price & Volume
Stats
See more52W Range | $20.38-$39.01 |
Market Cap | $1.2B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $723.3M |
Revenue Growth (YoY) | 0.3% |
Gross Profit (12 Mos) | $357M |
Diluted EPS | $2.26 |
News
See moreYahoo Finance • 19 days ago
Amphastar Director Sells 16,679 Shares for $441,800
Yahoo Finance • 22 days ago
Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO
Yahoo Finance • 26 days ago
Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals' (AMPH) Narrative?
Yahoo Finance • 27 days ago
Amphastar Announces FDA Approval for Teriparatide Injection
About
CEO | Dr. Yongfeng Zhang Ph.D. |
CFO | Mr. William J. Peters M.B.A. |
Address | 11570 6th Street, Rancho Cucamonga, CA, United States, 91730 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 2,028 |
